Top Markets
#1 Tensor Tensor +38.02%
#2 Blur Blur +20.11%
#3 Dymension Dymension +19.49%
#4 Supra Supra +15.93%
#5 XPIN Network XPIN Network +14.16%
#6 Irys Irys +13.12%
#7 Corn Corn +12.16%
#8 Ontology Gas Ontology Gas +12.16%
#9 Naoris Protocol Naoris Protocol +11.04%
#10 Enjin Coin Enjin Coin +9.82%
Coin of the day
Tensor Tensor
Settings
Language
ENGLISH
Currency
USD
Theme
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Rank in Stocks #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Share Price
$101.91
Market Cap
$177.09B
Change (1 day)
-1.97%
Change (1 year)
-19.78%
Country
US
Trade Abbott Laboratories (ABT)

Category

Healthcare
P/E ratio for Abbott Laboratories (ABT)
P/E ratio as of April 2026 TTM: 27.47
According to Abbott Laboratories latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.47. At the end of 2024 the company had a P/E ratio of 14.62.
P/E ratio history for Abbott Laboratories from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 27.47 -18.12%
2025 33.55 129.56%
2024 14.62 -56.18%
2023 33.35 20.14%
2022 27.76 -21.42%
2021 35.33 -18.19%
2020 43.19 3.69%
2019 41.65 -22.33%
2018 53.63 -74.29%
2017 208.61 416.25%
2016 40.41 170.24%
2015 14.95 -49.70%
2014 29.72 29.04%
2013 23.04 177.98%
2012 8.29 -7.25%
2011 8.93 16.57%
2010 7.66 10.25%
2009 6.95 -13.90%
2008 8.07 -29.75%
2007 11.49 -44.65%
2006 20.76 139.13%
2005 8.68 -19.34%
2004 10.76 -9.48%
2003 11.89 18.37%
2002 10.05 -59.93%
2001 25.07 107.16%
2000 12.10 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 38.72 40.95%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 24.08 -12.35%
IE
Medtronic Medtronic
Medtronic
MDT.US
 24.08 -12.35%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 32.19 17.19%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SMMNY.US
 19.12 -30.39%
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.